Recombinant Human Latent-transforming growth factor beta-binding protein 2 (LTBP2), partial

Code CSB-YP621790HU
MSDS
Size Pls inquire
Source Yeast
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-EP621790HU
MSDS
Size Pls inquire
Source E.coli
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-EP621790HU-B
MSDS
Size Pls inquire
Source E.coli
Conjugate Avi-tag Biotinylated
E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-BP621790HU
MSDS
Size Pls inquire
Source Baculovirus
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-MP621790HU
MSDS
Size Pls inquire
Source Mammalian cell
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Purity
>85% (SDS-PAGE)
Target Names
Uniprot No.
Alternative Names
C14orf141; Chromosome 14 open reading frame 141; Latent TGF beta binding protein 2; Latent transforming growth factor beta binding protein 2; Latent-transforming growth factor beta-binding protein 2; LTBP 2; LTBP 3; LTBP-2; Ltbp2; LTBP2_HUMAN; LTBP3; MSTP 031; MSTP031
Species
Homo sapiens (Human)
Protein Length
Partial
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
Form
Lyophilized powder
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
Buffer before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Reconstitution
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Troubleshooting and FAQs
Storage Condition
Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Shelf Life
The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Lead Time
Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet
Please contact us to get it.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
May play an integral structural role in elastic-fiber architectural organization and/or assembly.
Gene References into Functions
  1. Results revealed that the expression of LTBP2 was upregulated in gastric cancer (GC) tissues and cell lines. Increased LTBP2 expression was associated with poor overall survival in patients with early-stage [tumor-node-metastasis (TNM) I/II] and late-stage (TNM III/IV) GC. Furthermore, silencing of LTBP2 effectively suppressed the proliferation, migration, invasion and epithelial-mesenchymal transition in GC cells. PMID: 29620158
  2. effects of both oxidative stress and LTBP2 knockdown on the extracellular matrix and apoptosis may be mediated by TGFbeta and BMP signaling pathway activation PMID: 29908281
  3. LTBP2 is a novel biomarker for the diagnosis of pancreatic cancer. PMID: 28669978
  4. Our data suggest that LTBP2 acts as an oncogene in head and neck squamous cell carcinoma development and progression PMID: 27281608
  5. knockdown of LTBP2 inhibits invasion and tumorigenesis in thyroid carcinoma cells. PMID: 27712597
  6. We identified one nonsense mutation (c.2421G>A, p.W807X) in LTBP2 in eight Indian families. Among the mutations identified W807X in LTBP2 represent novel mutations. PMID: 28384041
  7. The results showed that no deleterious mutations were found in coding regions of LTBP2 in patients with PCG, suggesting that it is not a causal gene for primary congenital glaucoma in the Han Chinese population. PMID: 27293371
  8. LTBP-2 and FGF-2 are co-localized in fibrotic human keloid and hypertrophic scar. PMID: 26644005
  9. LTBP-2 is a potent inhibitor of FGF-2 that may influence FGF-2 bioactivity during wound repair particularly in fibrotic tissues. PMID: 26263555
  10. LTBP2 was able to reduce phosphorylation of p65 at Serine 536, inhibit nuclear localization of active phosphorylated p65, and impair the p65 DNA-binding ability. This results in a consequential down-regulation of p65-related gene expression. PMID: 25974126
  11. LTBP-2 is an essential component for the formation of microfibril bundles in ciliary zonules. PMID: 24908666
  12. perlecan HS was not essential for latent transforming growth factor-beta-1 binding protein-2 deposition PMID: 24867584
  13. Overall the results indicate that LTBP-2 may have a negative regulatory role during elastic fiber assembly, perhaps in displacing elastin microassemblies from complexes with fibulin-5 and/or cell surface heparan sulfate proteoglycans. PMID: 24148803
  14. Increased plasma levels of LTBP2 and/or OPN are present in plasma up to 2 years prior to diagnosis of hepatocellular carcinoma. PMID: 24803312
  15. Some LTBP2 sequence variations can contribute to the etiology of primary open angle glaucoma (POAG) and pseudoexfoliation (PEX) glaucoma syndrome. PMID: 23401661
  16. No pathogenic variants are identified in the LTBP2 gene in a cohort of patients with primary congenital glaucoma. PMID: 23378721
  17. LTBP2 mutations were not found in the Turkish GLC3C-linked primary congenital glaucoma (PCG) family or in 94 British CYP1B1-negative PCG cases. PMID: 22924778
  18. LTBP-2, in response to tension stress, may negatively control the function of fibulin-5, thereby modulating the mechanism of oxytalan fiber coalescence. PMID: 22827404
  19. This study analyzed CYP1B1, LTBP2, and MYOC mutations in a cohort of primary congenital glaucoma patients from the United States, applying whole exome sequencing PMID: 23218701
  20. Promoter hypermethylation was found to be involved in LTBP-2 silencing. PMID: 22743615
  21. Data show that median level of latent TGF-beta binding protein (LTBP) in myocardial samples from heart failure patients was significantly elevated. PMID: 22515403
  22. LTBP2 mutations cause Weill-Marchesani and Weill-Marchesani-like syndrome and affect disruptions in the extracellular matrix. PMID: 22539340
  23. plasma levels of LTBP2 present a novel and powerful predictor of all-cause mortality, and particularly pulmonary death PMID: 22587491
  24. Demonstrate specific immunolocalization of fibrillin-1, MAGP-1, and LTBP-1 with elastin in the outer annulus fibrosus of the fetal human intravertebral disc. PMID: 21540769
  25. Novel homozygous mutations in the LTBP-2 gene segregated with the phenotype in each affected consanguineous family cause congenital megalocornea with zonular weakness and childhood lens-related secondary glaucoma. PMID: 22025892
  26. A proteomic approach for identification and localization of the pericellular components of chondrocytes PMID: 21698479
  27. This study provided evidence that the IL-17A-197 G/A and TGFR-beta2-875 A/G genotype is closely related to hemorrhage risk for patients with brain arteriovenous malformation. PMID: 21737283
  28. Latent transforming growth factor beta-binding proteins-2 and -3 inhibit the proprotein convertase 5/6A. PMID: 21700711
  29. Preliminary observations on compounds with mutations in both CYP1B1-LTBP2 suggest that the observed combinations are of no clinical significance and digenic inheritance is unlikely. PMID: 21081970
  30. A susceptibility locus was identified on chromosome 14q24.3-31.2. The candidate functional gene is LTBP2. A suggestive linkage for mandibular prognathism in a Han Chinese pedigree. PMID: 21041550
  31. Study suggests a role for LTBP2 in the structural stability of ciliary zonules, and growth and development of lens. PMID: 20617341
  32. Biallelic null LTBP2 mutations cause the ocular phenotype in both families and could lead to Marfan-like features in older children. PMID: 20179738
  33. The authors reported that the isolated microspherophakia (MIM 251750) is caused by a mutation in the LTBP2 gene. The results suggested a role for LTBP2 in the growth and development of lens, and structural stability of ciliary zonules. PMID: 20617341
  34. LTBP-2 can play a role in melanoma cell adhesion PMID: 12716902
  35. These results suggest a novel regulatory mechanism of elastic fiber assembly in which LTBP-2 regulates targeting of DANCE on suitable microfibrils to form elastic fibers. PMID: 17581631
  36. LTBP2 is a novel positional candidate gene in chromosome 14q quantitative trait locos for bone density variation and fracture. PMID: 18697872
  37. LTBP2 is essential for normal development of the anterior chamber of the eye, where it may have a structural role in maintaining ciliary muscle tone. PMID: 19361779
  38. Loss of function mutations in LTBP2 cause the congenital glaucoma. PMID: 19656777
  39. Extracellular matrix association of LTBP-2 in cultured human embryonic lung fibroblasts depends on a pre-formed fibrillin-1 network. PMID: 19681046

Show More

Hide All

Involvement in disease
Glaucoma 3, primary congenital, D (GLC3D); Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma (MSPKA); Weill-Marchesani syndrome 3 (WMS3)
Subcellular Location
Secreted, extracellular space, extracellular matrix.
Protein Families
LTBP family
Tissue Specificity
Expressed in the aorta (at protein level). Expressed in lung, weakly expressed in heart, placenta, liver and skeletal muscle.
Database Links

HGNC: 6715

OMIM: 251750

KEGG: hsa:4053

STRING: 9606.ENSP00000261978

UniGene: Hs.512776

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2025 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1